Leo might you take a moment to share your thoughts on the below?
1) Would it be logical to believe that a sugar pill would’ve improved or kept cognition stable for 57-109 weeks in “most of our 32 patients”? Yes or no.
(If yes, please explain why sugar pills are not prescribed currently by neurologists as the standard of care?)
[As you’re aware our AD trial PI Professor Macfarlane recently was quoted as saying: “The cognition of most of the 32 patients who took part in the most recent trial remained stable, when it had been expected to decline.”]
2) That said, do you believe that a2-73 caused the stabilization and/or improvement? If not, then what do you propose caused “most” our participants to stabilize and some to improve?
3) Do you find the 2-3 years of safety data and minor side effects data for Anavex 2-73 to be a more favorable safety profile or less favorable safety profile compared to the currently available AD SOC drugs?
Thanks in advance.